150 related articles for article (PubMed ID: 22812260)
1. [Characteristics of the patients with primary Sjögren's syndrome complicated with lymphoma].
Li YQ; Yu QM; Li J; Yang JR; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):467-9. PubMed ID: 22812260
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases].
Jia N; Tang FL
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(39):2786-8. PubMed ID: 20137605
[TBL] [Abstract][Full Text] [Related]
3. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
4. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
5. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
7. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
8. [Malignant lymphoma associated with primary Sjögren's syndrome].
Wang L; Zhao Y; Zhang FC
Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(39):2773-5. PubMed ID: 21162916
[TBL] [Abstract][Full Text] [Related]
9. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome.
Voulgarelis M; Dafni UG; Isenberg DA; Moutsopoulos HM
Arthritis Rheum; 1999 Aug; 42(8):1765-72. PubMed ID: 10446879
[TBL] [Abstract][Full Text] [Related]
10. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
11. [The diagnosis and treatment of colorectal Non-Hodgkin's lymphoma 32 cases].
Zhou JL; Qiu HZ; Sun J; Li J
Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):290-4. PubMed ID: 21612690
[TBL] [Abstract][Full Text] [Related]
12. Sjogren's syndrome complicated by non-Hodgkin's lymphoma: spectrum of lymphoid proliferations and associated hepatitis C virus infection.
Awasthi NP; Kashyap R; Kumari N; Krishnani N
Indian J Pathol Microbiol; 2011; 54(2):430-1. PubMed ID: 21623127
[No Abstract] [Full Text] [Related]
13. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.
Theander E; Henriksson G; Ljungberg O; Mandl T; Manthorpe R; Jacobsson LT
Ann Rheum Dis; 2006 Jun; 65(6):796-803. PubMed ID: 16284097
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
16. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
Le Guern V; Mouthon L
Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
18. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
Nagai K
Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
[TBL] [Abstract][Full Text] [Related]
19. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
[TBL] [Abstract][Full Text] [Related]
20. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
Opriş D; Iosif CI; Predeţeanu D
Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]